Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
23.8%
% of GNOM's 42 holdings also in IDNA
21.7%
% of IDNA's 49 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
SAREPTA THERAPEUTICS INC | 3.9% | 4.8% | 3.9% |
|
MODERNA, INC. | 3.7% | 3.2% | 3.2% |
 |
BIONTECH SE SPONSORED ADR | 3.2% | 3.4% | 3.2% |
|
BEAM THERAPEUTICS, INC. | 2.9% | 2.2% | 2.2% |
|
GILEAD SCIENCES INC | 1.8% | 4.5% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to IDNA
 |
ENI SPA-SPONSORED ADR | 7.7% |
|
ALNYLAM PHARMACEUTICALS INC | 5.4% |
|
AVIDITY BIOSCIENCES INC | 5.3% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 4.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 4.0% |
|
BIO-TECHNE CORPORATION | 3.9% |
|
NATERA INC | 3.8% |
|
MYRIAD GENETICS INC | 3.6% |
|
INTELLIA THERAPEUTICS, INC. | 3.3% |
|
QIAGEN NV | 3.3% |
GNOM Underweight Relative to IDNA
 |
ROCHE HOLDING LTD | -4.7% |
|
REVOLUTION MEDICINES, INC. | -4.6% |
|
INCYTE CORP | -4.5% |
|
REGENERON PHARMACEUTICALS | -4.3% |
|
EXELIXIS INC | -4.2% |
 |
SANOFI-AVENTIS | -4.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.0% |
 |
GENMAB A/S | -3.9% |
|
MERCK & CO. INC. | -3.9% |
 |
GSK PLC | -3.8% |